Nuveen’s Blueprint Medicines BPMC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | – | Sell |
-488,612
| Closed | -$62.6M | – | 3262 |
|
|
2025
Q2 | $62.6M | Buy |
488,612
+220,952
| +83% | +$22.9M | 0.02% | 524 |
|
|
2025
Q1 | $23.4M | Sell |
267,660
-151,530
| -36% | -$14.8M | 0.01% | 1035 |
|
|
2024
Q4 | $36.6M | Buy |
419,190
+138,176
| +49% | +$12.7M | 0.01% | 809 |
|
|
2024
Q3 | $26M | Sell |
281,014
-58,479
| -17% | -$5.81M | 0.01% | 1014 |
|
|
2024
Q2 | $36.6M | Buy |
339,493
+73,146
| +27% | +$7.32M | 0.01% | 777 |
|
|
2024
Q1 | $25.3M | Sell |
266,347
-411
| -0.2% | -$35.2K | 0.01% | 1027 |
|
|
2023
Q4 | $24.6M | Buy |
266,758
+90,496
| +51% | +$5.86M | 0.01% | 1020 |
|
|
2023
Q3 | $8.85M | Buy |
176,262
+1,935
| +1% | +$103K | ﹤0.01% | 1554 |
|
|
2023
Q2 | $11M | Sell |
174,327
-5,623
| -3% | -$306K | ﹤0.01% | 1457 |
|
|
2023
Q1 | $8.1M | Sell |
179,950
-14,647
| -8% | -$660K | ﹤0.01% | 1619 |
|
|
2022
Q4 | $8.53M | Sell |
194,597
-6,994
| -3% | -$335K | ﹤0.01% | 1599 |
|
|
2022
Q3 | $13.3M | Sell |
201,591
-42,402
| -17% | -$2.72M | 0.01% | 1302 |
|
|
2022
Q2 | $12.3M | Buy |
243,993
+14,436
| +6% | +$846K | ﹤0.01% | 1379 |
|
|
2022
Q1 | $14.6M | Sell |
229,557
-135,898
| -37% | -$9.75M | ﹤0.01% | 1390 |
|
|
2021
Q4 | $39.1M | Buy |
365,455
+4,737
| +1% | +$495K | 0.01% | 814 |
|
|
2021
Q3 | $37.1M | Buy |
360,718
+6,248
| +2% | +$582K | 0.01% | 849 |
|
|
2021
Q2 | $31.2M | Buy |
354,470
+86,132
| +32% | +$7.89M | 0.01% | 1043 |
|
|
2021
Q1 | $26.1M | Sell |
268,338
-7,904
| -3% | -$789K | 0.01% | 1121 |
|
|
2020
Q4 | $31M | Sell |
276,242
-10,209
| -4% | -$1.08M | 0.01% | 961 |
|
|
2020
Q3 | $26.6M | Sell |
286,451
-98,558
| -26% | -$7.59M | 0.01% | 901 |
|
|
2020
Q2 | $30M | Sell |
385,009
-30,926
| -7% | -$2.09M | 0.01% | 793 |
|
|
2020
Q1 | $24.3M | Buy |
415,935
+172,088
| +71% | +$11.1M | 0.01% | 797 |
|
|
2019
Q4 | $19.5M | Buy |
243,847
+14,661
| +6% | +$1.1M | 0.01% | 1179 |
|
|
2019
Q3 | $16.8M | Buy |
229,186
+4,778
| +2% | +$413K | 0.01% | 1249 |
|
|
2019
Q2 | $21.2M | Buy |
224,408
+212,940
| +1,857% | +$17.6M | 0.01% | 1117 |
|
|
2019
Q1 | $918K | Buy |
+11,468
| New | +$847K | ﹤0.01% | 759 |
|
|
2018
Q3 | – | Sell |
-22,389
| Closed | -$1.42M | – | 1033 |
|
|
2018
Q2 | $1.42M | Buy |
22,389
+11,378
| +103% | +$905K | 0.01% | 667 |
|
|
2018
Q1 | $1.01M | Sell |
11,011
-5,405
| -33% | -$466K | 0.01% | 743 |
|
|
2017
Q4 | $1.24M | Sell |
16,416
-2,196
| -12% | -$155K | 0.01% | 694 |
|
|
2017
Q3 | $1.3M | Sell |
18,612
-3,761
| -17% | -$201K | 0.01% | 697 |
|
|
2017
Q2 | $1.13M | Sell |
22,373
-3,749
| -14% | -$159K | 0.01% | 728 |
|
|
2017
Q1 | $1.04M | Buy |
+26,122
| New | +$935K | 0.01% | 952 |
|
|
2015
Q3 | – | Sell |
-20,486
| Closed | -$543 | – | 1567 |
|
|
2015
Q2 | $543 | Buy |
+20,486
| New | +$585K | ﹤0.01% | 1337 |
|
Other funds holding BPMC
IA
HNB
Nuveen's BPMC Position: Q3 2025 in Review
Nuveen sold out of Blueprint Medicines (BPMC) in Q3 2025, closing a stake of 488,612 shares — an estimated $62.6M sold.
Nuveen first reported a position in BPMC in Q2 2015 and held it in 33 quarters. The position peaked at $62.6M in Q2 2025. 5 funds tracked by Wall St. Rank hold BPMC as of Q3 2025.
- Nuveen reported no remaining Blueprint Medicines position as of Q3 2025 after selling out during the quarter.
- Nuveen sold 488,612 Blueprint Medicines shares in Q3 2025, an estimated $62.6M.
- Nuveen first reported a position in Blueprint Medicines in Q2 2015 and held it in 33 quarters.
- Nuveen's Blueprint Medicines position peaked at $62.6M in Q2 2025.
- 5 funds tracked by Wall St. Rank held Blueprint Medicines as of Q3 2025.
Based on Nuveen's 13F filing for Q3 2025, filed 12 Nov 2025.